GlassScriptPhysician profile
Justin Michael Dexter
NPI 1336309723
$60,310.95
in general payments reported to CMS, 2019-2025
35 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $8,908 · 2021: $10K · 2022: $3,282 · 2023: $7,738 · 2024: $5,900 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $9,178 · Travel and Lodging: $1,472 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,900.00 |
| Food and Beverage | $9,178.10 |
| Travel and Lodging | $1,471.74 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $36,037.36 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $16,113.67 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Ocular Therapeutix, INC. | $1,280.42 | 2021-2025 | Dextenza |
| Ivantis, INC | $1,030.50 | 2020-2021 | |
| Glaukos Corporation | $617.09 | 2019-2025 | Idose, Idosetr, Iaccess Precision Blade |
| Allergan, INC. | $481.78 | 2019-2022 | |
| Oyster Point Pharma, INC. | $458.90 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Harrow Eye, LLC | $444.71 | 2023-2025 | Iheezo, Vevye, Triesence |
| Biotissue Holdings INC. | $432.81 | 2019-2025 | |
| Abbvie INC. | $411.63 | 2022-2025 | Durysta |
| Johnson & Johnson Surgical Vision, INC. | $407.03 | 2019-2025 | Tecnis Simplicity, Tecnis Iol |
| Amgen INC. | $330.32 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $301.59 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $259.09 | 2020-2025 | Cequa |
| Horizon Therapeutics Plc | $184.08 | 2022-2023 | Tepezza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $178.78 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $172.69 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Kala Pharmaceuticals, INC. | $144.31 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $134.04 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $120.83 | 2019 | |
| Thea Pharma INC. | $117.84 | 2023-2024 | Iyuzeh |
| Lkc Technologies, INC. | $110.90 | 2024 | |
| Spark Therapeutics, INC. | $106.17 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $80.68 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $67.39 | 2025 | Cirrus Hd-Oct |
| New World Medical,INC. | $60.28 | 2023-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Beaver-Visitec International, INC. | $38.98 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $37.35 | 2025 | Acthar |
| Rxsight INC | $35.14 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Alcon Research LLC | $26.71 | 2019 | |
| Apellis Pharmaceuticals, INC. | $22.68 | 2025 | Syfovre |
| Rayner Intraocular Lenses Limited | $20.80 | 2022 | |
| Dompe US, INC. | $16.59 | 2022 | |
| Omeros Corporation | $14.37 | 2019 | |
| Eyevance Pharmaceuticals LLC | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Dexter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.